Recent news on Olopatadine

Kyowa Hakko Fiscal 2006 Operating Income up 20.2%  -  Apr 26, 2007
Genetic Engineering News (press release),Sales of Coniel, a treatment for hypertension and angina pectoris, were lower than in the previous fiscal year, but sales of Allelock (olopatadine

Kyowa Hakko Kogyo submits NDA for Parkinson's drug  -  Apr 30, 2007
Pharma Times (subscription),Kyowa also suffered a decline in sales of its antihypertensive Coniel (benidipine), but the anti-allergy drug Allelock (olopatadine) and the anticancer

New formulation makes once-a-day allergy treatment possible  -  Apr 3, 2007
OSN SuperSite (subscription),Olopatadine 0.2% effectively treated ocular itching at the onset of allergic symptoms and at 16 hours, signaling a jump from twice-daily drops.

Inspire to Present Data at 2007 American Academy of Allergy ...  -  Feb 23, 2007
PharmaLive.com (press release),...cetirizine, desloratadine, fexofenadine, ketotifen and olopatadine, compared to bilastine and epinastine, related compounds in Inspire's portfolio.

Kyowa Hakko Nine-month Operating Income up 17.5%  -  Jan 29, 2007
PharmaLive.com (press release),Despite pharmaceutical price cuts introduced in April 2006, higher sales volumes of Allelock (olopatadine hydrochloride), an antiallergic agent,

Tussentijdse bedrijfsinkomsten Kyowa Hakko 18,4 procent gestegen  Oct 29, 2006
Sales of prescription pharmaceuticals such as Coniel, a treatment for hypertension and angina pectoris, and Allelock (olopatadine hydrochloride), an ... -Netherlands Corporate News (persbericht), New Antihistamine Nasal Spray Safe, with Less Incidence of Bad ...  -  Nov 13, 2006
DG NewsOlopatadine HCl 0.6% nasal spray, which contains an antihistamine and has mast cell stabilizing activity in vitro, was well tolerated, with a safety profile

Alcon Sues Apotex to Block Sales of Generic Patanol (Update1)  -  Nov 16, 2006
BloombergApotex is seeking US Food and Drug Administration approval to sell a copy of the treatment, whose key ingredient is olopatadine hydrochloride.

Allergists Explore Rising Prevalence and Unmet Needs Attributed to ...  -  Nov 13, 2006
SpiritIndia,...“These therapies include sublingual immunotherapy (SLIT), anti-IgE therapy, new topical nasal antihistamines (olopatadine) and new topical nasal

Patanol(R) (Olopatadine Hydrochloride Ophthalmic Solution) ...  Jul 27, 2006
...has received approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, Patanol® (olopatadine hydrochloride ophthalmic ... -DG News

Alcon's Eye Allergy Drug, PATANOL(R) Ophthalmic Solution, Approved ...  Jul 26, 2006
...receivedapproval from the Ministry of Health, Labor and Welfare in Japan tomarket its eye allergy drug, PATANOL(R) (olopatadine hydrochlorideophthalmic solution ... -Finanzen.net

Alcon's Eye Allergy Drug PATANOL Solution Approved In Japan ...  Jul 26, 2006
...received approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, PATANOL (olopatadine hydrochloride ophthalmic solution ... -Trading Markets

Alcon Japan, Kyowa Hakko Kogyo to Join Hands in Sales and ...  Jun 29, 2006
Tokyo, June 29, 2006 (JCN) - Alcon Japan and Kyowa Hakko Kogyo have signed an agreement for the olopatadine hydrochloride ophthalmic solution, a prescription ... -Japan Corporate News



Kyowa Hakko Profits Decline on Higher R&D Spend but Recurring ...  Apr 27, 2006
Allelock, an antiallergic agent (olopatadine hydrochloride),Durotep Patch, an analgesic for persistent cancer pain, and Navelbine,an anticancer agent, each ... - Finanzen.net





Alcon Labs withdraws EU allergy spray application  Feb 24, 2006
Opatanol (olopatadine hydrochloride) was first authorized in the European Union in May 2002 as eye drops for the treatment of ocular signs and symptoms of ... - Pharmaceutical Business Review

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional